These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 35563643)

  • 21. Cardiovascular disease in rheumatoid arthritis.
    Sen D; González-Mayda M; Brasington RD
    Rheum Dis Clin North Am; 2014 Feb; 40(1):27-49. PubMed ID: 24268008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
    Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
    Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Central Role of Acute Phase Proteins in Rheumatoid Arthritis: Involvement in Disease Autoimmunity, Inflammatory Responses, and the Heightened Risk of Cardiovascular Disease.
    Bezuidenhout JA; Pretorius E
    Semin Thromb Hemost; 2020 Jun; 46(4):465-483. PubMed ID: 32438423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis.
    Davies R; Williams J; Sime K; Jin HS; Thompson C; Jordan L; Lang D; Halcox JP; Ellins E; Jones GW; Jones SA; Rose-John S; Williams A; Choy E
    Rheumatology (Oxford); 2021 Jun; 60(6):2852-2861. PubMed ID: 33313793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A Synopsis.
    Gibofsky A
    Am J Manag Care; 2014 May; 20(7 Suppl):S128-35. PubMed ID: 25180621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis.
    Chang C; Xu L; Zhang R; Jin Y; Jiang P; Wei K; Xu L; Shi Y; Zhao J; Xiong M; Guo S; He D
    Front Immunol; 2022; 13():838884. PubMed ID: 35401568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Leukocyte Antigen Shared Epitope and Inflammation, Cardiovascular Disease, Cancer, and Mortality Among Postmenopausal Women in the Women's Health Initiative Rheumatoid Arthritis Study.
    Birru Talabi M; Mackey RH; Kuller LH; Dorman JS; Deane KD; Robinson WH; Walitt BT; Chang Y; Holers VM; Liu S; Moreland LW
    Am J Epidemiol; 2017 Jul; 186(2):245-254. PubMed ID: 28459968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets.
    Long H; Wang X; Chen Y; Wang L; Zhao M; Lu Q
    Cancer Lett; 2018 Aug; 428():90-103. PubMed ID: 29680223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extra-articular Manifestations and Comorbidity in Rheumatoid Arthritis: Potential Impact of Pre-Rheumatoid Arthritis Prevention.
    Giles JT
    Clin Ther; 2019 Jul; 41(7):1246-1255. PubMed ID: 31196641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
    Fragoulis GE; Panayotidis I; Nikiphorou E
    Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inflammation-related cardiovascular morbidity : Pathophysiology and therapy].
    Fischer-Betz R; Halle M; Schneider M
    Z Rheumatol; 2010 Oct; 69(8):680-4, 686-8. PubMed ID: 20862480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atherosclerosis and rheumatoid arthritis: more than a simple association.
    Cavagna L; Boffini N; Cagnotto G; Inverardi F; Grosso V; Caporali R
    Mediators Inflamm; 2012; 2012():147354. PubMed ID: 23024462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.
    García-Bermúdez M; González-Juanatey C; López-Mejías R; Teruel M; Corrales A; Miranda-Filloy JA; Castañeda S; Balsa A; Fernández-Gutierrez B; González-Álvaro I; Gómez-Vaquero C; Blanco R; Llorca J; Martín J; González-Gay MA
    PLoS One; 2012; 7(11):e49214. PubMed ID: 23166616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis.
    Kmiołek T; Paradowska-Gorycka A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis.
    Verhoeven F; Prati C; Maguin-Gaté K; Wendling D; Demougeot C
    Arthritis Res Ther; 2016 Nov; 18(1):258. PubMed ID: 27814748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers.
    López-Mejías R; Castañeda S; González-Juanatey C; Corrales A; Ferraz-Amaro I; Genre F; Remuzgo-Martínez S; Rodriguez-Rodriguez L; Blanco R; Llorca J; Martín J; González-Gay MA
    Autoimmun Rev; 2016 Nov; 15(11):1013-1030. PubMed ID: 27490206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.
    Dixon WG; Symmons DP
    Ann Rheum Dis; 2007 Sep; 66(9):1132-6. PubMed ID: 17251223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients.
    García-Bermúdez M; López-Mejías R; González-Juanatey C; Corrales A; Castañeda S; Ortiz AM; Miranda-Filloy JA; Gómez-Vaquero C; Fernández-Gutiérrez B; Balsa A; Pascual-Salcedo D; Blanco R; Llorca J; Martín J; González-Gay MA
    DNA Cell Biol; 2013 Jan; 32(1):28-33. PubMed ID: 23088220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
    Choy E; Ganeshalingam K; Semb AG; Szekanecz Z; Nurmohamed M
    Rheumatology (Oxford); 2014 Dec; 53(12):2143-54. PubMed ID: 24907149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.